Advertisement

Epidemiology of anti-HCV antibodies in France

  • O. Agulles
  • C. Janot
  • Viral Hepatitis Study Group of the French Blood Transfusion Society
Part of the Archives of Virology book series (ARCHIVES SUPPL, volume 4)

Summary

The aim of this large survey which covered 173,038 unselected blood donors, was to determine the seroprevalence of anti-HCV antibodies and surrogate markers (ALT and anti-HBc) in France. The results revealed a frequency of 0.63% of anti-HCV positive donors. The correlation with surrogate markers was very poor but since we know nothing about the infectivity of anti-HCV negative donations, screening of surrogate markers must still be performed to prevent post-transfusional hepatitis.

Keywords

Blood Donor Viral Hepatitis Surrogate Marker Positive Donor ELISA Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Weiner A J, Truett MA, Rosenblatt J, Han J, Quan S, Polito A J, Küo G, Choo Q-L, Houghton M (1991) HCV: Immunologic and hybridization-based diagnostics. In: Hollinger FB, Lemon SM, Margolis H (eds) Viral hepatitis and liver disease. Williams & Wilkins, Baltimore, pp 360–363Google Scholar
  2. 2.
    Courouce AM, Janot C et le Groupe de Travail “Hépatites Virales” de la Société Nationale de Transfusion Sanguine (1990) Test de confirmation de l’anticorps anti-VHC. XVème Congrès de la Société Nationale de Transfusion Sanguine. BesanconGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • O. Agulles
    • 1
  • C. Janot
    • 1
  • Viral Hepatitis Study Group of the French Blood Transfusion Society
    • 1
  1. 1.CRTSVandoeuvreFrance

Personalised recommendations